Pfizer Inc. (NYSE:PFE) has agreed to pay $325 million to settle a lawsuit brought by health-care benefit providers who claimed the drug maker marketed the epilepsy drug Neurontin for unapproved uses. Pfizer Inc. (NYSE:PFE) net profit margin is 81.20% and weekly performance is 0.75%. On last trading day company shares ended up $29.71. Analysts mean target price for the company is $34.45. Pfizer Inc. (NYSE:PFE) distance from 50-day simple moving average (SMA50) is -2.17%.
Abbott Laboratories (NYSE:ABT) recently announced a $2.9 billion acquisition of the Chilean generic drug maker CFR Pharmaceuticals. Abbott Laboratories (NYSE:ABT) shares fell -0.52% in last trading session and ended the day on $39.80. ABT gross Margin is 54.00% and its return on assets is 6.90%.Abbott Laboratories (NYSE:ABT) quarterly performance is 1.79%.
Chicago, the third-biggest U.S. city, sued Johnson & Johnson (NYSE:JNJ) and four other drug companies for allegedly pushing consumer use of opioid painkillers, creating addicts and driving up its costs. Johnson & Johnson (NYSE:JNJ) shares moved up 0.70% in last trading session and was closed at $102.17, while trading in range of $101.01 – $102.26. Johnson & Johnson (NYSE:JNJ) year to date (YTD) performance is 13.13%.
Eli Lilly and Company (NYSE:LLY) announced detailed results from REVEL, a global Phase III study of CYRAMZA™ (ramucirumab) in combination with chemotherapy in patients with second-line non-small cell lung cancer (NSCLC). Eli Lilly and Co (NYSE:LLY) ended the last trading day at $59.49. Company weekly volatility is calculated as 1.20% and price to cash ratio as 12.78.Eli Lilly and Co (NYSE:LLY) showed a negative weekly performance of -0.52%.
Adherex Technologies Inc. (OTCMKTS:ADHXF) on 30 may announced that the nominees listed in the management proxy circular dated April 28,2014 (the “Circular”) for the Annual and Special Meeting of Shareholders were elected as directors of the Company at the Annual and Special Meeting of Shareholders held in Durham, North Carolina on May 28, 2014 (the “Meeting”). On last trading day company shares ended up $1.57.